×

Neurostimulator Device Market Size, Share, Trends, Growth Outlook

The Global Neurostimulator Device Market Size is estimated to register high growth over the forecast period from 2023 to 2030.

 

The market growth is driven by the increasing prevalence of neurological disorders such as epilepsy, Parkinson's disease, chronic pain, and depression is a significant driver for the neurostimulator device market. These devices offer therapeutic solutions for patients who do not respond well to traditional treatments.  Leading companies that are focused on Expanding Applications, Personalized Medicine, Improved Electrode Technologies, Closed-Loop Systems, Digital Health Integration, Investment and Research, and others to boost market shares in the industry.

 

Market Overview

The neurostimulator device market is a rapidly growing sector focused on modulating the nervous system for therapeutic purposes. It encompasses various device types such as spinal cord stimulators, deep brain stimulators, and cochlear implants, targeting applications from chronic pain management to hearing loss. Major players like Medtronic and Abbott invest in innovation, while regulatory approvals and reimbursement challenges persist. With a global presence, the market is expanding beyond North America and Europe into regions like Asia-Pacific.

 

Market Dynamics

Market Trends- Benefits of Telemedicine and Remote Monitoring for Neurostimulator Devices

Telemedicine and remote monitoring provide enhanced access, convenience, and safety for patients using neurostimulator devices by enabling remote consultations, real-time monitoring, and data-driven adjustments, thus reducing the need for in-person visits, lowering healthcare costs, and improving treatment outcomes. These technologies empower patients to actively engage in their care, ensure early issue detection, and maintain therapy continuity while offering healthcare providers valuable insights and efficient, patient-centered care.

 

Market Driver- - Wireless and Wearable Devices Demand Neurostimulator Device Market

The demand for wireless and wearable neurostimulator devices is increasing due to their potential to enhance patient comfort, compliance, and treatment outcomes. These devices offer real-time monitoring, remote adjustments, improved patient mobility, and expanded applications while eliminating the need for surgical implantation, making them a more patient-friendly and adaptable option in the neurostimulator device market.

 

Market Opportunity-Introduction of Advancements in Technology

Advancements in technology for the neurostimulator device market encompass improved electrode design, wireless connectivity, miniaturization, closed-loop systems, artificial intelligence, enhanced battery technology, patient-friendly interfaces, minimally invasive implantation techniques, biocompatible materials, advanced neuroimaging, neuroprosthetics, and robotics. These advancements are collectively enhancing the precision, comfort, longevity, and adaptability of neurostimulation therapies, offering more personalized and effective treatments for patients with neurological conditions and disorders.

 

Market Share Analysis- Spinal Cord Stimulator Neurostimulator Device Market will register the fastest growth

The Global Neurostimulator Device Market is analyzed across Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator, and others. Of these, Spinal Cord Stimulators are poised to register the fastest growth. Spinal Cord Stimulator (SCS) devices, a significant segment of the neurostimulator device market, are surgically implanted to manage chronic pain conditions by delivering electrical impulses to the spinal cord, disrupting pain signals. They are increasingly in demand as non-opioid alternatives due to the opioid crisis. While effective for many patients, proper patient selection, long-term efficacy, and device-related complications are challenges. Advancements in wireless technology and ongoing research aim to improve SCS devices and enhance pain management outcomes.

 

Market Share Analysis- Pain Management held a significant market share in 2023

The Global Neurostimulator Device Market is analyzed across a wide range of applications including Pain Management, Epilepsy, Essential tremors, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, and others. Of these, Pain Management held a significant market share in 2023. Pain management is a prominent application within the neurostimulator device market, addressing chronic pain conditions through various neurostimulation devices, including Spinal Cord Stimulators (SCS) and Peripheral Nerve Stimulators (PNS). These devices modulate the nervous system to reduce or interrupt pain signals, serving as non-opioid alternatives amid the opioid crisis. Patient selection, efficacy, device-related issues, and ongoing research for enhancements are key facets of this segment, which plays a crucial role in improving the quality of life for patients suffering from chronic and neuropathic pain conditions.

 

Neurostimulator Device Market Segmentation

By Type

  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Gastric Electric Stimulator
  • Others

By Application

  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Others

By Region

  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Spain, Italy, Others)
  • Asia Pacific (China, India, Japan, South Korea, Australia, Others)
  • Latin America (Brazil, Argentina, Others)
  • Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Neurostimulator Device Market Companies

  • Medtronic Inc (Ireland)
  • Cyberonics Inc (United States)
  • CVRx Inc (United States)
  • Boston Scientific Corp (United States)
  • NeuroSigma Inc (United States)
  • St. Jude Medical Inc (United States)
  • Neuropace Inc (United States)
  • Bioness Inc (United States)
  • Enter Medics Inc (United States)
  • Aleva Neurotherapeutics SA(Switzerland)

 

*List not exhaustive

 

Neurostimulator Device Market Outlook 2023

1 Market Overview

1.1 Introduction to the Neurostimulator Device Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Neurostimulator Device Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Neurostimulator Device Market Companies with Area Served

4.2.2 Products Offerings Global Neurostimulator Device Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 Post-COVID-19 Scenario- Low Growth Case

5.1.3 Post-COVID-19 Scenario- Reference Growth Case

5.1.4 Post-COVID-19 Scenario- Low Growth Case

 

6 Global Neurostimulator Device Market Trends

6.1 Global Neurostimulator Device Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Neurostimulator Device Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Neurostimulator Device Revenue (USD Million) and CAGR (%) by Regions (2018-2030)

 

7 Global Neurostimulator Device Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Neurostimulator Device Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Neurostimulator Device Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Neurostimulator Device Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Neurostimulator Device Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Neurostimulator Device Development Regional Status and Outlook

8.1 Global Neurostimulator Device Revenue (USD Million) By Regions (2018-2022)

8.2 North America Neurostimulator Device Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Neurostimulator Device Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Neurostimulator Device Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Neurostimulator Device Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Neurostimulator Device Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Neurostimulator Device Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Neurostimulator Device Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Neurostimulator Device Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Neurostimulator Device Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Neurostimulator Device Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Neurostimulator Device Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Neurostimulator Device Revenue (USD Million) by Applications (2018-2022)

8.5 South America Neurostimulator Device Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Neurostimulator Device Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Neurostimulator Device Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Neurostimulator Device Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Neurostimulator Device Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Neurostimulator Device Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Neurostimulator Device Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Neurostimulator Device Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Neurostimulator Device Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Neurostimulator Device Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Neurostimulator Device Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Neurostimulator Device Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Neurostimulator Device Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Neurostimulator Device Development Regional Status and Outlook Forecast

11.1 Global Neurostimulator Device Revenue (USD Million) By Regions (2023-2030)

11.2 North America Neurostimulator Device Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Neurostimulator Device Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Neurostimulator Device Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Neurostimulator Device Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Neurostimulator Device Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Neurostimulator Device Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Neurostimulator Device Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Neurostimulator Device Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Neurostimulator Device Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Neurostimulator Device Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Neurostimulator Device Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Neurostimulator Device Revenue (USD Million), by Applications (2023-2030)

11.5 South America Neurostimulator Device Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Neurostimulator Device Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Neurostimulator Device Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Neurostimulator Device Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Neurostimulator Device Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Neurostimulator Device Revenue (USD Million), by Region (2023-2030)

11.6.2 Middle East and Africa Neurostimulator Device Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Neurostimulator Device Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Neurostimulator Device Market Companies with Areas Served

Table 3 Products Offerings Global Neurostimulator Device Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Neurostimulator Device Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Neurostimulator Device Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Neurostimulator Device Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Table 11 Global Neurostimulator Device Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Neurostimulator Device Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Neurostimulator Device Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Neurostimulator Device Market Share (%) By Regions (2018-2022)

Table 16 North America Neurostimulator Device Revenue (USD Million) By Country (2018-2022)

Table 17 North America Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Table 18 North America Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Neurostimulator Device Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Neurostimulator Device Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Neurostimulator Device Revenue (USD Million) By Country (2018-2022)

Table 26 South America Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Table 27 South America Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Table 33 Global Neurostimulator Device Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Neurostimulator Device Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Neurostimulator Device Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Neurostimulator Device Revenue (USD)By Country (2023-2030)

Table 38 North America Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Table 39 North America Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Neurostimulator Device Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Neurostimulator Device Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Neurostimulator Device Revenue (USD Million) By Country (2023-2030)

Table 47 South America Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Table 48 South America Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Neurostimulator Device Revenue Market Share (%) By Type (2022)

Figure 5 Global Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Neurostimulator Device Revenue Market Share (%) By Applications (2022)

Figure 7 Global Neurostimulator Device Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Neurostimulator Device Market Share (%) By Regions (2022)

Figure 9 North America Neurostimulator Device Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Neurostimulator Device Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Neurostimulator Device Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Neurostimulator Device Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Neurostimulator Device Revenue Market Share (%) By Type (2030)

Figure 26 Global Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Neurostimulator Device Revenue Market Share (%) By Applications (2030)

Figure 28 Global Neurostimulator Device Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Neurostimulator Device Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Neurostimulator Device Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Neurostimulator Device Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Neurostimulator Device Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Neurostimulator Device Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches For This Report

Figure 46 Data Triangulation

 

Neurostimulator Device Market Segmentation

By Type

  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Gastric Electric Stimulator
  • Others

By Application

  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Others

By Region

  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Spain, Italy, Others)
  • Asia Pacific (China, India, Japan, South Korea, Australia, Others)
  • Latin America (Brazil, Argentina, Others)
  • Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

Related Reports